Keeping in mind the Senate will reconvene on Tuesday:
Senate Agenda
Hide Senate-16th Legislative Day-3/28/2023View PDF
| Legislation | Sponsor | Title | ||
|---|---|---|---|---|
| SS 1 for SB 1 | Townsend | AN ACT TO AMEND TITLE 25 OF THE DELAWARE CODE RELATING TO THE RESIDENTIAL LANDLORD-TENANT CODE. | ||
| HB 1 | Osienski | AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO MARIJUANA. | ||
| HB 2 w/ HA 1, HA 2 | Osienski | AN ACT TO AMEND TITLES 4, 11, 16, AND 30 OF THE DELAWARE CODE RELATING TO CREATION OF THE DELAWARE MARIJUANA CONTROL ACT. |
A frustrated Delaware medical marijuana provider accused a testing company of charging “grossly higher” fees than those in other states.
The exchange took place Thursday evening in the Medical Marijuana Stakeholder Group, after Daniel Woodall, president, and chemist at the High Tide Lab Co., talked about testing marijuana for medicinal companies in the state.
“I would like to make a comment,” said Michael Wiser, president of the Compassionate Care Research Institute.
Wiser told the group he is concerned about the increased cost of testing. Compassionate Care spends more than $1 million dollars a year on testing, Wiser said.
“To be perfectly frank with you, we’ve operated in five states, and the fees that you’re charging are grossly higher than any other state we’ve operated in,” he said. “Just want to register that we are complaining about it. We think that the amount that you’re charging is exorbitant.”
Woodall responded “That’s bullcrap. That is such garbage.”
Woodall said he didn’t appreciate the insinuation that the testing fees are responsible for increases in prices.
“There’s no way that the testing fee is an excuse,” he said. “You guys have charged the same amount of money forever. It’s the same price; don’t blame that on the lab. I don’t set your prices.
“That’s such garbage, I’m sorry, buddy, but that’s such garbage. Sir, I will consider your statements. But don’t say that high prices are because of the lab.”
Continue reading and follow: https://delawarelive.com/medical-marijuana-meeting-gets-testy/
SAM HAUT MARCH 17, 2023
Note: We wonder if this will be part of the dialog during the hearing part of the Senate legislative session this week. Also note that last session The Joint Legislative Oversight and Sunset Committee completed a review of same said aforementioned Medical Marijuana Board in Delaware directly before the 152 Legislative Session voted on the legalization of the green leaf. The Q&A in that JLOSC meeting was contentious as well. Have you been paying attention to our post enough to find the recording on https://legis.delaware.gov/?
